Related Experiment Video

Updated: Aug 11, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Hospital-acquired pneumonia: etiologic considerations

Amalia Alcón1, Neus Fàbregas, Antoni Torres

  • 1Surgical Intensive Care Unit, Servicio de Anestesiología, Hospital Clínic, Barcelona University, Villarroel 170, 08036 Barcelona, Spain.

Infectious Disease Clinics of North America
|March 11, 2004
PubMed

Insights

Pneumonia develops when pathogens overwhelm host defenses, originating from endogenous or exogenous sources. Understanding pneumonia origins and onset timing is crucial for effective treatment and prevention strategies.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pneumonia pathogenesis involves pathogen entry into alveoli and host defense compromise.
  • Microorganism sources include endogenous colonization (nasal, oral, gastric) and exogenous factors (medical devices).

Purpose of the Study:

  • To explore the origins and sources of pneumonia-causing microorganisms.
  • To discuss the challenges in defining pneumonia onset and terminology.

Main Methods:

  • Literature review of pneumonia development and microbial sources.
  • Analysis of factors influencing microbial virulence and host susceptibility.
  • Discussion of clinical definitions and terminology related to pneumonia onset.

Main Results:

  • Pneumonia requires pathogen invasion and host defense failure, influenced by virulence and inoculum size.
  • Diverse endogenous and exogenous microbial sources contribute to pneumonia.
  • Variations in causative agents exist based on pneumonia onset and institutional/geographic factors.

Conclusions:

  • Accurate pneumonia diagnosis and treatment depend on identifying microbial sources and understanding onset timing.
  • The definition of early vs. late-onset pneumonia requires clarification.
  • The term "ventilator-associated pneumonia" may be better replaced by "intubation-associated pneumonia" due to noninvasive ventilation advancements.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...